Cargando…

Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study

OBJECTIVE: Most patients with atrial fibrillation (AF) have risk factors and coexisting conditions that increase their mortality risk. We performed a cause-of-death analysis to identify predictors of mortality in hospitalised patients with AF in France. METHODS AND RESULTS: In this retrospective, po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fauchier, Laurent, Samson, Adeline, Chaize, Gwendoline, Gaudin, Anne-Françoise, Vainchtock, Alexandre, Bailly, Cécile, Cotté, Francois-Emery
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680587/ https://www.ncbi.nlm.nih.gov/pubmed/26688739 http://dx.doi.org/10.1136/openhrt-2015-000290

Ejemplares similares

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France
por: Cotté, Francois-Emery, et al.
Publicado: (2016)

Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland
por: Lehto, Mika, et al.
Publicado: (2022)

Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China
por: Du, Xin, et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Inflammatory proteomics profiling for prediction of incident atrial fibrillation
por: Börschel, Christin S, et al.
Publicado: (2023)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Association of income and health-related quality of life in atrial fibrillation
por: Guhl, Emily, et al.
Publicado: (2019)

Catheter ablation for the management of atrial fibrillation: current technical perspectives
por: Hong, Kathryn Lauren, et al.
Publicado: (2020)

Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
por: Moschovitis, Giorgio, et al.
Publicado: (2021)

Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014
por: Kjerpeseth, Lars Jøran, et al.
Publicado: (2021)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Impact of COVID-19 on patients awaiting ablation for atrial fibrillation
por: Pius, Charlene, et al.
Publicado: (2022)

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation
por: Melduni, Rowlens M, et al.
Publicado: (2020)

Quality of life and healthcare utilisation improvements after atrial fibrillation ablation
por: Gupta, Dhiraj, et al.
Publicado: (2021)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Characterising symptom clusters in patients with atrial fibrillation undergoing catheter ablation
por: Hobensack, Mollie, et al.
Publicado: (2023)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Development and validation of prediction models for incident atrial fibrillation in heart failure
por: Vinter, Nicklas, et al.
Publicado: (2023)

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Hidden burden of arrhythmias in patients with small atrial septal defects: a nationwide study
por: Udholm, Sebastian, et al.
Publicado: (2019)

Risk of out-of-hospital cardiac arrest in patients with rheumatoid arthritis: a nationwide study
por: Hegazy, Hatem, et al.
Publicado: (2022)

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)

Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence
por: Higashiya, Shunichi, et al.
Publicado: (2017)

Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
por: Gallagher, Celine, et al.
Publicado: (2020)

Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation
por: Jackson, Adam, et al.
Publicado: (2021)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports
por: Chavez, Patricia, et al.
Publicado: (2015)

Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review
por: Kane, Sarah A, et al.
Publicado: (2016)

Reducing radiation exposure during atrial fibrillation ablation using lectures to promote awareness
por: Miwa, Yosuke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a4b3t68o238eborqgqhmm0b429